Cargando…
Formulation and Characterization of Antigen-loaded PLGA Nanoparticles for Efficient Cross-priming of the Antigen
BACKGROUND: Nanoparticles (NPs) prepared from biodegradable polymers, such as poly (D,L-lactic acid-co-glycolic acid) (PLGA), have been studied as vehicles for the delivery of antigens to phagocytes. This paper describes the preparation of antigen-loaded PLGA-NPs for efficient cross-priming. METHODS...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Immunologists
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153668/ https://www.ncbi.nlm.nih.gov/pubmed/21860609 http://dx.doi.org/10.4110/in.2011.11.3.163 |
_version_ | 1782209916868493312 |
---|---|
author | Lee, Young-Ran Lee, Young-Hee Im, Sun-A Kim, Kyungjae Lee, Chong-Kil |
author_facet | Lee, Young-Ran Lee, Young-Hee Im, Sun-A Kim, Kyungjae Lee, Chong-Kil |
author_sort | Lee, Young-Ran |
collection | PubMed |
description | BACKGROUND: Nanoparticles (NPs) prepared from biodegradable polymers, such as poly (D,L-lactic acid-co-glycolic acid) (PLGA), have been studied as vehicles for the delivery of antigens to phagocytes. This paper describes the preparation of antigen-loaded PLGA-NPs for efficient cross-priming. METHODS: NPs containing a similar amount of ovalbumin (OVA) but different sizes were produced using a micromixer-based W/O/W solvent evaporation procedure, and the efficiency of the NPs to induce the cross-presentation of OVA peptides were examined in dendritic cells (DCs). Cellular uptake and biodistribution studies were performed using fluorescein isothiocyanate (FITC)-loaded NPs in mice. RESULTS: The NPs in the range of 1.1~1.4µm in size were the most and almost equally efficient in inducing the cross-presentation of OVA peptides via H-2K(b) molecules. Cellular uptake and biodistribution studies showed that opsonization of the NPs with mouse IgG greatly increased the percentage of FITC-positive cells in the spleen and lymph nodes. The major cell type of FITC-positive cells in the spleen was macrophages, whereas that of lymph nodes was DCs. CONCLUSION: These results show that IgG-opsonized PLGA-NPs with a mean size of 1.1µm would be the choice of biodegradable carriers for the targeted-delivery of protein antigens for cross-priming in vivo. |
format | Online Article Text |
id | pubmed-3153668 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | The Korean Association of Immunologists |
record_format | MEDLINE/PubMed |
spelling | pubmed-31536682011-08-22 Formulation and Characterization of Antigen-loaded PLGA Nanoparticles for Efficient Cross-priming of the Antigen Lee, Young-Ran Lee, Young-Hee Im, Sun-A Kim, Kyungjae Lee, Chong-Kil Immune Netw Original Article BACKGROUND: Nanoparticles (NPs) prepared from biodegradable polymers, such as poly (D,L-lactic acid-co-glycolic acid) (PLGA), have been studied as vehicles for the delivery of antigens to phagocytes. This paper describes the preparation of antigen-loaded PLGA-NPs for efficient cross-priming. METHODS: NPs containing a similar amount of ovalbumin (OVA) but different sizes were produced using a micromixer-based W/O/W solvent evaporation procedure, and the efficiency of the NPs to induce the cross-presentation of OVA peptides were examined in dendritic cells (DCs). Cellular uptake and biodistribution studies were performed using fluorescein isothiocyanate (FITC)-loaded NPs in mice. RESULTS: The NPs in the range of 1.1~1.4µm in size were the most and almost equally efficient in inducing the cross-presentation of OVA peptides via H-2K(b) molecules. Cellular uptake and biodistribution studies showed that opsonization of the NPs with mouse IgG greatly increased the percentage of FITC-positive cells in the spleen and lymph nodes. The major cell type of FITC-positive cells in the spleen was macrophages, whereas that of lymph nodes was DCs. CONCLUSION: These results show that IgG-opsonized PLGA-NPs with a mean size of 1.1µm would be the choice of biodegradable carriers for the targeted-delivery of protein antigens for cross-priming in vivo. The Korean Association of Immunologists 2011-06 2011-06-30 /pmc/articles/PMC3153668/ /pubmed/21860609 http://dx.doi.org/10.4110/in.2011.11.3.163 Text en Copyright © 2011 The Korean Association of Immunologists http://creativecommons.org/licenses/by-nc/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Lee, Young-Ran Lee, Young-Hee Im, Sun-A Kim, Kyungjae Lee, Chong-Kil Formulation and Characterization of Antigen-loaded PLGA Nanoparticles for Efficient Cross-priming of the Antigen |
title | Formulation and Characterization of Antigen-loaded PLGA Nanoparticles for Efficient Cross-priming of the Antigen |
title_full | Formulation and Characterization of Antigen-loaded PLGA Nanoparticles for Efficient Cross-priming of the Antigen |
title_fullStr | Formulation and Characterization of Antigen-loaded PLGA Nanoparticles for Efficient Cross-priming of the Antigen |
title_full_unstemmed | Formulation and Characterization of Antigen-loaded PLGA Nanoparticles for Efficient Cross-priming of the Antigen |
title_short | Formulation and Characterization of Antigen-loaded PLGA Nanoparticles for Efficient Cross-priming of the Antigen |
title_sort | formulation and characterization of antigen-loaded plga nanoparticles for efficient cross-priming of the antigen |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153668/ https://www.ncbi.nlm.nih.gov/pubmed/21860609 http://dx.doi.org/10.4110/in.2011.11.3.163 |
work_keys_str_mv | AT leeyoungran formulationandcharacterizationofantigenloadedplgananoparticlesforefficientcrossprimingoftheantigen AT leeyounghee formulationandcharacterizationofantigenloadedplgananoparticlesforefficientcrossprimingoftheantigen AT imsuna formulationandcharacterizationofantigenloadedplgananoparticlesforefficientcrossprimingoftheantigen AT kimkyungjae formulationandcharacterizationofantigenloadedplgananoparticlesforefficientcrossprimingoftheantigen AT leechongkil formulationandcharacterizationofantigenloadedplgananoparticlesforefficientcrossprimingoftheantigen |